Next Science Limited (NXSCF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 22.17 Million | 11.71 Million | 8.94 Million | 3.44 Million | 4.06 Million |
| Cost of Revenue | 5.94 Million | 2.56 Million | 2 Million | 524.13 Thousand | 550.48 Thousand |
| Gross Profit | 16.23 Million | 9.14 Million | 6.94 Million | 2.91 Million | 3.51 Million |
| Operating Expenses | 33.37 Million | 22.74 Million | 16.54 Million | 15.44 Million | 16.04 Million |
| Selling, General and Administrative Expenses | 25.77 Million | 15.69 Million | 11.27 Million | 8.79 Million | 9.09 Million |
| Research and Development Expenses | 6.48 Million | 6.14 Million | 4.47 Million | 5.95 Million | 1.73 Million |
| Other Expenses | 99.4 Thousand | 71.97 Thousand | 265.44 Thousand | 543.78 Thousand | 73.69 Thousand |
| Cost and Expenses | 39.31 Million | 25.3 Million | 18.55 Million | 15.97 Million | 16.59 Million |
| Operating Income | -15.5 Million | -13.54 Million | -9.59 Million | -12.52 Million | -12.25 Million |
| Interest Expense | 735.91 Thousand | 28.6 Thousand | 16.47 Thousand | 21.17 Thousand | 2.1 Million |
| Income Tax Expense | - | -837.13 Thousand | 7537.00 | -75.51 Thousand | 2.17 Million |
| Earnings before Tax | -16.27 Million | -12.68 Million | -9.34 Million | -11.91 Million | -14.35 Million |
| Net Income | -16.27 Million | -12.68 Million | -9.34 Million | -11.91 Million | -14.35 Million |
| Earnings Per Share Basic | -0.07 | -0.06 | - | - | -0.09 |
| Earnings Per Share Diluted | -0.07 | -0.06 | - | - | -0.09 |
| Weighted Average Shares Outstanding | 234.09 Million | 210.46 Million | - | - | 165.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 234.09 Million | 210.46 Million | - | - | 165.97 Million |
| Gross Margin | 0.73 | 0.78 | 0.78 | 0.85 | 0.86 |
| EBIT Margin | -0.65 | -1.08 | -0.98 | -3.43 | -2.88 |
| Profit Margin | -0.73 | -1.08 | -1.04 | -3.46 | -3.53 |
| EBITDA | -14.42 Million | -12.69 Million | -9.6 Million | -11.82 Million | -11.68 Million |
| Earnings Before Tax Margin | -0.70 | -1.16 | -1.07 | -3.64 | -3.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.61 Million | 5.61 Million | 22.17 Million | 12.59 Million | 6.03 Million | 9.96 Million |
| Cost of Revenue | 1.13 Million | 1.13 Million | 5.94 Million | 3.38 Million | 1.33 Million | 3.76 Million |
| Gross Profit | 4.48 Million | 4.48 Million | 16.23 Million | 9.2 Million | 4.7 Million | 6.2 Million |
| Operating Expenses | 7.41 Million | 7.41 Million | 33.37 Million | 17.3 Million | 8.36 Million | 14.36 Million |
| Selling, General and Administrative Expenses | 5.95 Million | 5.95 Million | - | 14.04 Million | 7.02 Million | 11.04 Million |
| Research and Development Expenses | 1.66 Million | 1.66 Million | - | 3.25 Million | 1.67 Million | 3.31 Million |
| Other Expenses | -207.99 Thousand | -207.99 Thousand | 99.4 Thousand | - | - | - |
| Cost and Expenses | 8.55 Million | 8.55 Million | 39.31 Million | 20.68 Million | 9.69 Million | 18.12 Million |
| Operating Income | -2.93 Million | -2.93 Million | -15.5 Million | -8.09 Million | -3.83 Million | -8.15 Million |
| Interest Expense | 41.76 Thousand | - | 735.91 Thousand | 398.69 Thousand | - | 396.64 Thousand |
| Income Tax Expense | -2.00 | - | 835.31 Thousand | 1.00 | - | - |
| Earnings before Tax | -2.92 Million | -2.92 Million | -16.27 Million | -7.98 Million | -3.82 Million | -8.49 Million |
| Net Income | -2.92 Million | -2.92 Million | -16.27 Million | -7.98 Million | -3.82 Million | -8.49 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | - | -0.03 | -0.02 | -0.04 |
| Earnings Per Share Diluted | -0.01 | -0.01 | - | -0.03 | -0.02 | -0.04 |
| Weighted Average Shares Outstanding | 291.71 Million | 291.71 Million | 234.09 Million | 260.42 Million | 253.41 Million | 214.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 291.69 Million | 291.69 Million | 234.09 Million | 260.42 Million | 253.39 Million | 214.79 Million |
| Gross Margin | 0.80 | 0.80 | 0.73 | 0.73 | 0.78 | 0.62 |
| EBIT Margin | -0.47 | -0.47 | - | -0.59 | -0.62 | -0.77 |
| Profit Margin | -0.52 | -0.52 | -0.73 | -0.63 | -0.63 | -0.85 |
| EBITDA | -2.63 Million | -2.63 Million | - | -7.48 Million | -3.73 Million | -7.62 Million |
| Earnings Before Tax Margin | -0.52 | -0.52 | -0.70 | -0.64 | -0.64 | -0.82 |
AYMSYNTEX
VAPIENTER
300562
ARTZF
0204
ISGIF